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Highlights 
 
 Several theories of ageing have been proposed since the late 19th century, including a 
large number of studies linking the mitochondria to ageing.  
 
 Accumulation of oxidative damage over time as a result of elevated levels of reactive 
oxygen species, damage to mitochondrial DNA and mitochondrial dysfunction can 
lead to loss of cellular function and characteristic hallmarks of ageing. 
 
 The skin is often used to study human ageing, due to its easy accessibility, and the 
observation that the ageing process is able to be accelerated in this organ via 
environmental insults, such as ultra violet radiation. 
 
 A wide range of diseases are associated with ageing; therefore, understanding the 
cause of the ageing process as well as regulatory mechanisms involved could provide 
potentially advantageous therapeutic targets for the prevention or treatment of such 
diseases. 
 
 
Abstract 
Ageing describes the progressive functional decline of an organism over time, leading to an 
increase in susceptibility to age-related diseases and eventually to death, and it is a 
phenomenon observed across a wide range of organisms. Despite a vast repertoire of ageing 
studies performed over the past century, the exact causes of ageing remain unknown. For 
over 50 years it has been speculated that mitochondria play a key role in the ageing process, 
due mainly to correlative data showing an increase in mitochondrial dysfunction, 
mitochondrial DNA (mtDNA) damage, and reactive oxygen species (ROS) with age. 
However, the exact role of the mitochondria in the ageing process remains unknown.  
The skin is often used to study human ageing, due to its easy accessibility, and the 
observation that the ageing process is able to be accelerated in this organ via environmental 
insults, such as ultra violet radiation (UVR). This provides a useful tool to investigate the 
mechanisms regulating ageing and, in particular, the role of the mitochondria. Observations 
from dermatological and photoageing studies can provide useful insights into chronological 
ageing of the skin and other organs such as the brain and liver. Moreover, a wide range of 
diseases are associated with ageing; therefore, understanding the cause of the ageing process 
as well as regulatory mechanisms involved could provide potentially advantageous 
therapeutic targets for the prevention or treatment of such diseases. 
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Introduction 
 
Ageing describes the functional decline of an organism over time, which occurs across all 
tissues of the body, leading to an increase in susceptibility to age-related diseases including 
cancer, and eventually the death of the organism [1]. It is a phenomenon observed across 
different organisms, however the exact mechanism as to how and why we age remains 
largely unknown despite modern medicine, increased social awareness and advances in 
hygiene and diet which have dramatically increased the average human life expectancy over 
the last century [2]. It is important therefore to understand the mechanisms of ageing so that 
the ever-increasing elderly population can maintain their health for as long as possible, as 
well as providing mechanistic insight into diseases whereby age is a significant risk factor 
such as Alzheimer’s disease (AD) and cancer [3]. Understanding the cause of the ageing 
process could provide potentially advantageous therapeutic targets for the prevention or 
treatment of such diseases. This review aims to explore the important role that mitochondria 
play in the ageing process, with particular emphasis on the use of skin as a highly 
advantageous model and surrogate for investigations into such mechanisms. 
 
The Role of Mitochondria in Ageing 
 
There are several theories of ageing that have been proposed since the late 19th century 
including the ‘wear and tear theory of ageing’, the ‘antagonistic pleiotropy theory of ageing’ 
and the ‘disposable soma theory of ageing’. Strong evidence exists both in support and 
against these published theories which have been reviewed previously and therefore will not 
be discussed herein [4-6]. Of more interest is the large number of studies into how and why 
we age that involve the mitochondria. Mitochondria are dynamic organelles found within the 
cytoplasm of eukaryotic cells, and are responsible for the production of the majority of 
cellular energy via oxidative phosphorylation and the electron transport chain (ETC), in the 
form of adenosine triphosphate (ATP) [7]. A natural by-product of oxygen metabolism in the 
mitochondria is the formation of reactive oxygen species (ROS). ROS have important roles in 
cell signalling and homeostasis, however, in times of environmental stress, levels can 
increase dramatically which can result in significant damage to cell structures. Unlike nuclear 
DNA (nDNA), multiple copies of mitochondrial DNA (mtDNA) exist within each cell and 
are found in close proximity to the electron transport chain (ETC) making them extremely 
vulnerable to the effects of oxidative stress, exacerbated further by the fact that mtDNA has 
limited repair mechanisms [8]. As mtDNA encodes 13 subunits of the ETC plus the assembly 
machinery, ROS-induced damage has the potential to alter ETC function and decrease the 
efficiency of ATP production. An example of a theory of ageing involving the mitochondria 
is the ‘rate of living theory of ageing’ which was proposed in 1928 by Raymond Pearl [9], 
who presented the idea that the differing metabolic rates between animal species was a 
determining factor in maximum lifespan potential. This theory was taken further by Denham 
Harman in 1956 [10], who proposed the ‘free radical theory of ageing’, which suggested that 
the rate of production of free radicals such as ROS, rather than the rate of metabolic activity 
directly, affected the ageing process of the animal. Highly reactive oxygen radicals were 
proposed to cause damage to biological structures which was thought to accumulate over 
time, eventually leading to a loss of cellular function and ageing [10]. In support of this 
theory, it has been observed that pigeons have approximately 9-fold longer maximal lifespans 
than rats, despite similar masses and metabolic rates; however, the rate of H2O2 production is 
significantly lower in pigeons [11-13]. This could imply that animals which generate fewer 
free radicals have longer lifespans. Additionally, both mice and rats have different metabolic 
rates, yet a similar level of H2O2 production, and their maximal lifespans are the same [13]. 
Further evidence for a role of free radicals in lifespan determination is based on the 
observation that the level of oxidative mtDNA damage in heart tissue is lower in longer-lived 
mammals [14, 15]. As mitochondria are responsible for the production of the majority of 
ROS within a cell [16] and the fact that not all oxidants are free radicals, the free radical 
theory of ageing was later refined to the ‘mitochondrial theory of ageing’ in 1972 and is 
currently one of the most widely accepted theories of ageing [17]. 
 
Accumulation of oxidative damage over time as a result of elevated ROS, mtDNA damage 
and mitochondrial dysfunction can lead to loss of cellular function and characteristic 
hallmarks of ageing further supporting a key role for mitochondria in the ageing process. The 
mitochondrial theory of ageing is based around the idea of a vicious cycle (figure 1) [18]. 
This theory suggests that ROS production from the ETC is able to cause damage to mtDNA, 
and because mtDNA encodes subunits of the ETC, this then leads to errors in gene expression 
and results in dysfunctional subunits. Dysfunctional mitochondria are then thought to 
contribute to further ROS leakage, in a continuous vicious cycle of damage accumulation [18, 
19]. Whilst there is no definite proof that this model exists, evidence does exists in support of 
it and highlights an interesting concept in the understanding of the various mechanisms and 
components involved in mitochondrial-related ageing. The three stages of the vicious cycle 
(namely, increased ROS, mtDNA damage, and mitochondrial dysfunction) have been shown 
in previous studies to be able to occur independently and to be correlated with increased age. 
For example, Hayakawa et al., found that the level of mtDNA damage (8-oxo-dG lesions) 
was higher in the human heart muscle of older people compared to younger. In the study, 
mtDNA damage increased exponentially from 45 years and older [20]; this lends support to 
the exponential increase in damage which is thought to occur during the vicious cycle theory 
of ageing. Other studies have also shown an increase in oxidative mtDNA damage with age 
[21]. Higher levels of mtDNA mutations have also been shown to be causative in terms of 
ageing phenotypes; Trifunovic et al. and Kujoth et al. found that mice with accelerated 
mtDNA mutation levels (via a mutated mtDNA polymerase) showed increased mitochondrial 
dysfunction, as well as reduced longevity and an accelerated onset of ageing phenotypes [22, 
23]. Additionally, mtDNA mutations and deletions have been shown to correlate with the 
ageing process; for example, the 4977 bp common deletion which may be used as a 
biomarker for general mtDNA damage, has been shown to accumulate in certain human 
tissues with age [24]. The T414G mtDNA point mutation has also been shown to be higher in 
the skin of older individuals [25]. 
 
In terms of a relationship between mitochondrial dysfunction and age, past work has shown 
that the individual complexes of the ETC decline with age in some tissues from different 
species [26, 27]. The mitochondrial membrane potential has also been shown to be decreased 
with age in specific tissues, as has the ATP-producing capability of mitochondria. However, 
Lapointe et al., (2012) demonstrated that not all forms of mitochondrial dysfunction are 
detrimental in terms of lifespan, as mice with lower levels of ubiquinone showed 
mitochondrial dysfunction in the form of decreased respiratory activity, as well as increased 
oxidative stress, but these mice actually had increased longevity compared to wild-type mice 
[28]. The study suggested that mitochondrial dysfunction can result in ROS release, yet this 
ROS release may not necessarily contribute to a vicious cycle and a decrease in lifespan [28]. 
This has also been observed for Caenorhabditis elegans (C. elegans), for which ETC activity 
was lowered during development using RNA interference (RNAi), which resulted in 
increased lifespans [29]. These results suggest a complex relationship between mitochondrial 
function and age and so the vicious cycle theory remains disputed [19]. However, the 
mitochondria are still extremely likely to play a major role in the ageing process [30], even if 
not necessarily via a vicious cycle of damage. 
 
More recently an interesting concept has been introduced in the field of mitochondria and 
ageing termed mitohormesis. This idea was developed based on observations that the 
relationship between ROS generation and ageing is not linear; low concentrations of ROS can 
induce a positive response whilst higher concentrations of ROS promotes damage (figure 1)  
[31]. This theory could provide an explanation for the observations discussed above, that an 
increase in ROS and/or mitochondrial dysfunction does not negatively impact lifespan and 
the ageing process [28]. In fact, evidence suggests that oxidative stress, induced by range of 
stressors, could delay the onset of age-related conditions and potentially extend lifespan [29]. 
There has been increasing appreciation for the beneficial role of ROS in cell signalling events 
such as signal transduction, gene regulation and redox regulation suggesting that low 
concentrations of ROS are physiologically vital to life and completely eliminating ROS may 
be detrimental [32]. This may explain the observation by Morley and Trainor that mice fed a 
life-long vitamin E supplemented diet showed no improvements in life span [33]. In support 
of this, Perez et al reviewed their extensive studies investigating the effect of over or under 
expressing eighteen genes regulating antioxidant enzymes and observed that only one (the 
deletion of sod1) had an effect on lifespan [34]. Although it is of note that other studies have 
found a beneficial effect on ageing with antioxidant supplementation [35] and it is likely that 
other factors are involved, such as localisation of dietary and endogenous antioxidants to the 
site of ROS generation in the mitochondria. Whilst it is unquestionably accepted that high 
levels of oxidative stress have a negative impact of cellular function and extensive evidence 
exists linking high levels of ROS to ageing, mitohormesis introduces an interesting concept 
that different levels of oxidative stress may have opposite biological outcomes [36]. 
Furthermore, this added complexity to the mitochondrial theories of ageing may significantly 
impact future research and treatment and/or prevention strategies for age-related diseases and 
ageing itself. 
 
 
Several studies have linked a reduction in adult stem cells to age-related diseases and that 
increasing adult stem cells can delay ageing [37]. Gaining further insights into the 
mechanisms regulating mitochondrial activity during stem cell ageing and the effect of 
mtDNA damage on this will provide greater knowledge into the role mitochondria play in 
ageing and highlight potential therapeutic targets. 
 
The term senescence describes the transformation of cells from a proliferating to a non-
proliferating state, as a tumour suppressive mechanism to prevent cells with potentially 
cancerous DNA mutations from undergoing replication. During this process cells lose the 
ability to divide yet remain viable. This is in contrast to biological ageing which describes the 
functional decline of a whole organism over time eventually leading to death, although the 
two processes are linked with senescence being thought to play a prominent role in ageing 
[38]. Senescent cells have been shown to be increased in an age-dependant manner in many 
tissues and organisms, including humans. Mitochondrial dysfunction is thought to play a role 
in the increased levels of senescent cells observed with age [39, 40]. Previous studies have 
shown that mice with knocked-down MnSOD have higher levels of mitochondrial ROS 
production, and an increased number of senescent cells, suggesting a causal role for 
mitochondrial ROS in senescence [27]. These mice also showed accelerated ageing 
phenotypes and a reduced lifespan, implicating a role for both senescence and mitochondria 
in ageing. Other studies suggesting a causal role of mitochondria in senescence have been 
performed in human lung fibroblasts, for which it was found that a decrease in superoxide 
production by the mitochondria (via uncoupling) resulted in a decreased number of senescent 
cells [39]. ROS production by inhibition of complex I has also been shown to lead to 
senescence in human skin fibroblasts, and mitochondrial complex III inhibition has been 
shown to induce senescence in a human lung fibroblast cell line. 
 
In human lung fibroblast cells, it was found that p21 activation (which induces senescence) is 
able to induce mitochondrial dysfunction (decreased mitochondrial membrane potential) and 
increase ROS production [41]. This ROS production by the mitochondria following 
senescence was shown to be necessary for maintaining the senescent phenotype, by 
maintaining DNA damage and the DNA damage response [41]. This could potentially imply 
that an increase in mitochondrial dysfunction and ROS production with age are both a cause 
and a consequence of increased senescence levels with age. This could extend the vicious 
cycle theory of ageing further by introducing an additional interacting factor to contribute to 
mitochondrial dysfunction and ROS, whilst also itself being affected by ROS. The role of 
mtDNA damage in senescence remains unclear, however it has been suggested that mtDNA 
damage contributes to the senescent phenotype by increasing mitochondrial dysfunction and 
ROS, which ties-in with the vicious cycle theory of ageing. MtDNA damage has also been 
shown to be higher in senescent cells, by measuring the level of damage via qPCR within an 
11 kb section of the mitochondrial genome [39]. However, not all cells in older organisms 
become senescent, as the induction of senescence is a stress response which only occurs in a 
minority of cells exposed to unfavourable conditions, or with mutations leading to oncogenic 
activation. More recently complex II has been shown to be implicated in human dermal 
fibroblast senescence and ageing [8, 38, 42]. Bowman et al demonstrated that complex II 
activity, transcript and protein levels decrease with age. Moreover, these effects are only seen 
in senescent cell populations. This result was shown to be specific to complex II as no change 
with complex IV was observed. The authors further speculate that this decrease in complex II 
activity could result in an increase in ROS resulting in mtDNA damage and oxidative stress 
which are known to contribute to the ageing process [38].  
 
Whilst vast evidence exists implicating mitochondria in the ageing process, until recently 
there was no conclusive proof that mitochondria are major triggers of cell ageing. Correia-
Melo et al. induced mitochondrial degradation to completely eliminate all mitochondria and 
demonstrated that these cells did not undergo hallmark changes of cellular senescence in 
terms of inflammatory molecules, oxygen free radicals and gene expression. However, cell 
cycle arrest still occurred, thereby maintaining the tumour suppressive properties of the cells. 
This study demonstrates for the first time that mitochondria are pivotal in the ability of a cell 
to senesce and the ageing process [43].   
 
Skin: a model organ for investigating the role of mitochondria in ageing 
 The skin can undergo two distinct types of ageing; intrinsic (chronological) and extrinsic 
ageing (photoageing). The skin is often used to study human ageing, due to its easy 
accessibility, and the observation that the ageing process is able to be accelerated in this 
organ via environmental insults, such as ultra violet radiation (UVR) [25, 44]. The exposed 
nature of the skin means it is at more risk of environmental insults than most organs [45], and 
the characteristics of aged skin such as wrinkles, laxity, uneven pigmentation, brown spots 
and a leathery appearance are most prominent in areas of the body which are most exposed to 
UVR such as the face and the hands. This suggests that these characteristics of ageing can be 
accelerated by UVR, an occurrence known as photoageing [25].  
 
Solar radiation is comprised of UVR (UVA and UVB), visible light and infrared (IR) [44] 
with a relative contribution of approximately 6%, 40% and 54% respectively. UVR from the 
sun is the main extrinsic influence of skin ageing; excessive exposure to UVR can lead to 
cellular, molecular, and genetic changes in the skin, which if unrepaired can have deleterious 
effects on cellular function [19, 46]. Sunburn is generally observed a few hours after acute 
exposure to UVR; however, more serious effects of chronic UVR exposure include 
immunosuppression, increased risk of skin cancer due to DNA mutations, and accelerated 
skin ageing [46]. UVR is able to cause damage to cells either by the production of ROS or via 
direct DNA damage. In terms of UVR-induced ageing, both UVA and UVB have been shown 
to contribute, however alterations within the dermis appear to be the fundamental cause of the 
aforementioned visual signs of ageing. Due to its ability to penetrate to the deeper layers of 
skin, UVA has been identified as a major contributor to photoaged skin [46]. UVR can 
induce the expression of matrix metalloproteinases (MMPs) which can degrade the collagen 
and elastin components of the dermis leading to increased formation of wrinkles.  
 
A possible mechanism as to how UVR is able to accelerate the ageing process could be via its 
interaction with mitochondria, where it may contribute to a vicious cycle of increasing 
damage, which has been strongly linked  to the ageing process [19, 45]. In this scenario, UVR 
may increase ROS levels, or cause mtDNA damage directly, which could result in an increase 
in mitochondrial dysfunction and a further production of ROS in a continuing vicious cycle. 
Even if this vicious cycle is not occurring, any damage to mtDNA or mitochondria directly 
by UVR could still result in an increase in photoageing, as mitochondria are thought to play a 
prominent role in the ageing process [19]. This has led to the development of mtDNA as an 
established biomarker of UVR-induced damage [47]. Furthermore, there is a strong positive 
correlation between many of the same symptoms and mtDNA mutations found in photo-aged 
skin compared to chronologically aged skin; therefore, excessively UV-exposed skin may be 
used as a model for skin from older individuals [47]. For example, the mtDNA 3895 bp and 
4977 bp deletions, as well as the T414G mutation, are correlated more strongly with skin 
from sun-exposed regions and also in the skin of older individuals [25, 47]. 
 
Whilst the role UVR plays in mitochondria damage induced photoageing has been explored, 
relatively little is known about the role of IRR in photoageing and/or mitochondria damage. 
IRR makes up 54% of solar light and evidence exists that it has a detrimental effect on human 
skin. Investigations to date have observed an increase in intracellular ROS following 
irradiation with IR, which is known to have a strong correlation to mitochondria damage, as 
discussed previously [48]. Additionally, IRR has been shown to effect gene expression of 
MMPs which break down collagen and lead to characteristic photoaged skin. However, in 
contrast to UVR, the low energy level of IRR means it is poorly absorbed by chromophores 
such as melanin or directly affect DNA, therefore another mechanism must explain these 
damaging effects [44]. Interestingly, the mitochondria is believed to be a key cellular target 
involved in the pathogenesis of IRR induced premature ageing in the skin via the enzyme 
cytochrome C Oxidase (also known as complex IV of the ETC) acting as a chromophore for 
IRA leading to disruptions within the ETC and defective energy production. Consequently, 
cellular signalling cascades are initiated which alter gene expression of key proteins involved 
in photoageing e.g. MMPs leading to the visual appearance of photoageing skin [44].  
 
 
 
 
Less attention has been given to the role of environmental pollutants in skin ageing [49], for 
example air pollution is a growing concern with established links between chronic exposure 
to environmental pollutants and respiratory, cardiovascular, and more recently skin diseases 
[19]. Pollutants have been shown to have a negative effect on skin function, however what is 
less clear is the mechanistic regulation of such effects. Recent investigations have 
demonstrated the potential of various pollutants to form free radicals in the skin and linked 
this to classical visible signs of skin ageing such as wrinkles. Furthermore, environmental 
contaminants have been observed to target the mitochondria suggesting a relationship 
between environmental insult and mitochondrial-induced skin ageing in a similar manner to 
that induced by solar radiation. For example, pollutants such as polycyclic aromatic 
hydrocarbons which are formed from the incomplete combustion of organic material such as 
oil and coal, have been shown to cause more mtDNA damage than nDNA damage [50]. 
Particulate matter (PM) and cigarette smoke have also been reported to cause their damaging 
effects through mitochondrial toxicity, although it has not been established whether these 
effects are the primary or secondary to effects elsewhere [50]. Hou et al. showed for the first 
time in 2010 a direct link between PM exposure and mtDNA damage. This study analysed 
the blood of 63 male steel workers and correlated mtDNA copy number, an established 
marker of mitochondria damage to individual PM exposure. These findings support in vitro 
data demonstrating that PM can cause ROS-induced disruption to the mitochondrion [51]. 
Whilst further work is required to support the relationship between pollution and premature 
ageing via mitochondria-mediated mechanisms, it provides important evidence to enhance 
knowledge on the role mitochondria play in the ageing process in both skin and other organs 
exposed to environmental pollutants such as lungs.  
 
An interesting theory has recently been put forward which suggests that mtDNA damage is 
not the cause of the cellular, molecular and functional changes associated with ageing rather 
that ageing precedes mtDNA damage [52]. A hallmark characteristic of dermal fibroblasts in 
aged skin is reduced spreading and contact with collagen fibrils. This results in a change in 
cellular morphology and the normally elongated spindle-like cells become short and circular. 
The authors suggest that an age-induced reduction in fibroblast spreading causes an increase 
in ROS which consequently damages mtDNA [52]. This is in contrast to general consensus 
that mtDNA damage and elevated ROS levels causes age-associated changes. This 
investigation introduces an interesting concept that ageing is a cycling and dynamic process 
of positive feedback mechanisms whereby age-related changes in cells results in mtDNA 
damage and oxidative stress, which in turn lead to further age-related changes in cells and so 
on.  
 
Sunscreens in protecting mitochondrial induced ageing  
The advantageous properties of the skin as a model to investigate mechanisms regulating 
ageing can be extended to include its use in assessing the protective abilities of topical 
treatments. It is well established that UVR can result in elevated ROS and damage to mtDNA 
which can damage the skin leading to premature skin ageing. Therefore, in order to prevent 
photoageing from occurring, as well as minimising the risk of other damaging effects of solar 
radiation such as skin cancer, it is advised to regularly apply sunscreen as part of a 
recommended sun protection regime. The active ingredients found in sunscreen formulations 
are categorised as being either physical (mineral) or chemical (organic) compounds. Physical 
sunscreens such as titanium dioxide (TiO2) and zinc oxide (ZnO) are thought to shield the 
skin by absorbing, reflecting and scattering UVA and UVB whilst chemical sunscreens 
protect by absorbing UVA and or UVB. Older generation sunscreens provided protection 
against UVB whilst allowing for UVA to pass through the skin. UVA was later recognised as 
being a contributing factor to skin cancer in the 1980s as well as being the primary cause of 
photo ageing [53]. This led to the development of broad spectrum formulations containing 
both UVA and UVB filters which are now regulated by strict European guidelines.   
Studies investigating the protective effects of UVA filters in sunscreens on UVR-induced 
molecular damage are limited. However, Bruge et al. recently demonstrated that BMDM 
(Butyl Methoxydibenzoylmethane), a widely used chemical UVA filter has the ability to 
reduce UVA induced ROS generation, decrease the level of DNA damage, reduce expression 
of the enzyme MMP1 and maintain mitochondrial membrane potential [54]. The ability of 
commercially available sunscreens to reduce UV induced free radical production has also 
been investigated. When applied at the recommended dose of 2mg/cm2 the sunscreens 
assessed reduced free radical production by 55%. Lower amounts of sunscreen (0.5-
1.5mg/cm2) simulating the average amount applied by consumers reduced free radical 
production by 46% [55]. These studies provide evidence that the use of sunscreens, in 
particular those containing UVA filters, provide protection against UVR-induced 
mitochondrial damage and consequently may delay the ageing process in skin and 
highlighting an important ‘proof of concept’ that mitochondria-related ageing can be 
regulated topically.  
Based on the evidence that UVR-induced ROS generation within a cell is detrimental to 
mitochondrial function and may lead to photoageing, it has been speculated that sunscreen 
supplementation with antioxidants such as vitamin C, vitamin E and polyphenols may offer 
further protection in addition to the primary chemical and physical active ingredients [56]. 
Matsui et al. assessed the ability of topical antioxidants to reduce UV induced skin damage. 
The application of sunscreen alone showed a 43% decrease in MMP1 expression compared to 
the UV control. The sunscreens supplemented with antioxidants showed a higher level of 
protection with a 60% decrease in MMP1 expression [57]. Furthermore, Tiron, an antioxidant 
which is preferentially localized to the mitochondria, exhibits complete (100%) protection 
against UVA and H2O2 induced mitochondrial DNA damage in human dermal fibroblasts 
[46].  
 
 
Ageing in other organs 
 
Whilst skin is an advantageous model for investigating the role of mitochondria in ageing, 
other organs show similar patterns regarding a decline in mitochondrial function, increase in 
mtDNA damage and elevated ROS with ageing [20]. This relationship is particularly strong 
in organs with high metabolic activity for example the brain and liver [58]. The brain has 
high energy demands and a gradual decrease in energy metabolism as well as elevated ROS 
levels have been reported in the ageing brain and some neurodegenerative disorders resulting 
in a hypometabolic state. Mitochondria play a key role in energy production and therefore, a 
reduction in expression and activity of respiratory chain complexes as well as increases in 
mtDNA mutations have been shown to further contribute to this dysfunctional state [59]. 
Moreover, mitochondrial defects associated with elevated ROS are hallmarks of both the 
ageing and Alzheimer’s disease (AD) brain [3, 59].  Indeed, it has been shown that 
mitochondrial dysfunction precedes Aβ plaques and neurofibrillary tangles; the established 
markers of AD, furthermore alterations to mitochondrial morphology and ETC complexes 
were noted in autopsy samples from Alzheimer’s patients and a higher number of mtDNA 
mutations were observed in AD patients compared to age-matched controls [3]. Antioxidant 
supplementation has been shown, with variable success, to reduce age-related mitochondrial 
dysfunction in the brain and therefore highlights an interesting therapeutic option for the 
treatment of age-related neurological diseases such as AD [58]. Additionally, age related 
changes in digestion, metabolism and clearance of drugs have been attributed to declining 
function of the liver with age. Mitochondria have also been implicated in the aging liver with 
a decrease in mitochondria number and a reduction in respiratory chain enzymes. Indeed, a 
study found that 87% of those above 50 years had defects in the respiratory chain caused by 
loss of mitochondrial coded subunits [58].  
 
Conclusion 
A wide range of diseases are associated with ageing, therefore, understanding the cause of the 
ageing process as well as regulatory mechanisms involved could provide potentially 
advantageous therapeutic targets for the prevention or treatment of such diseases. Attempts to 
elucidate the mechanisms of ageing have been performed and many interesting theories have 
been suggested, in particular those implicating the mitochondria. However, the ageing 
process is still not fully understood, and therefore more work is required before attempts to 
slow the ageing process can be carried out. More recent developments in the field of 
mitohormesis provides an interesting concept for the varying roles oxidative stress plays in 
ageing. Whilst more research into the specific molecular effects and biological outcomes are 
required, it supports evidence that mitochondria are heavily implicated in the ageing process, 
although the exact role it plays appears to be more complex than originally postulated.  
 
 
 
Contributors 
All authors participated in the writing of the paper and approved the final version.  
 
Conflict of interest  
None declared.  
 
Funding 
The authors received no funding for this article. 
 
Provenance and peer review  
This article has undergone peer review. 
 
Ethical Approval 
No ethical approval was required for this review.  
 
List of contributors 
 
Laura Hudson: 
I declare that I participated in the writing and proof reading of the review entitled 
“Mitochondria Damage and Ageing review” and that I have seen and approved the final 
version. I have no conflicts of interest.  
 
Amy Bowman: 
I declare that I participated in the writing and proof reading of the review entitled 
“Mitochondria Damage and Ageing review” and that I have seen and approved the final 
version. I have no conflicts of interest.  
 
Eyman Rashdan: 
I declare that I participated in the writing and proof reading of the review entitled 
“Mitochondria Damage and Ageing review” and that I have seen and approved the final 
version. I have no conflicts of interest.  
 
Mark Birch-Machin: 
I declare that I participated in the writing and proof reading of the review entitled 
“Mitochondria Damage and Ageing review” and that I have seen and approved the final 
version. I have no conflicts of interest.  
  
 
 
 
 
 
References 
 
 
1. Judith, C., Aging, Cellular Senescence, and Cancer. Annual Review of Physiology, 2013. 75(1): 
p. 685-705. 
2. Finch, C.E., Evolution of the human lifespan, past, present, and future: phases in the 
evolution of human life expectancy in relation to the inflammatory load. Proceedings of the 
American Philosophical Society, 2012. 156(1): p. 9-44. 
3. Wong, H., et al., RCAN1 overexpression promotes age-dependent mitochondrial 
dysregulation related to neurodegeneration in Alzheimer’s disease. Acta Neuropathologica, 
2015. 130(6): p. 829-843. 
4. Goldsmith, T.C., Aging as an evolved characteristic - Weismann's theory reconsidered. 
Medical Hypotheses, 2004. 62(2): p. 304-308. 
5. Fabian, D.F., T. , The Evolution of Aging. Nature Education Knowledge 2011. 3(10): p. 9. 
6. Blagosklonny, M.V., Why the disposable soma theory cannot explain why women live longer 
and why we age. Aging (Albany NY), 2010. 2(12): p. 884-887. 
7. Birch-Machin, M.A., The role of mitochondria in ageing and carcinogenesis. Clinical and 
Experimental Dermatology, 2006. 31(4): p. 548-552. 
8. Anderson, A., et al., A role for human mitochondrial complex II in the production of reactive 
oxygen species in human skin. Redox Biology, 2014. 2: p. 1016-1022. 
9. Pearl, R. The Rate of Living. 1928. 
10. Harman, D., Aging: a theory based on free radical and radiation chemistry. J Gerontol, 1956. 
11(3): p. 298-300. 
11. Ku, H.H. and R.S. Sohal, Comparison of mitochondrial pro-oxidant generation and anti-
oxidant defenses between rat and pigeon: possible basis of variation in longevity and 
metabolic potential. Mechanisms of Ageing and Development, 1993. 72(1): p. 67-76. 
12. Barja, G., et al., Low mitochondrial free radical production per unit o2 consumption can 
explain the simultaneous presence of high longevity and high aerobic metabolic rate in birds. 
Free Radical Research, 1994. 21(5): p. 317-327. 
13. Barja, G. and A. Herrero, Localization at complex I and mechanism of the higher free radical 
production of brain nonsynaptic mitochondria in the short-lived rat than in the longevous 
pigeon. Journal of Bioenergetics and Biomembranes, 1998. 30(3): p. 235-243. 
14. Barja, G. and A. Herrero, Oxidative damage to mitochondrial DNA is inversely related to 
maximum life span in the heart and brain of mammals. FASEB Journal, 2000. 14(2): p. 312-
318. 
15. Barja, G., Rate of generation of oxidative stress-related damage and animal longevity. Free 
Radical Biology and Medicine, 2002. 33(9): p. 1167-1172. 
16. Berg, J.M., Tymoczko, J.L. and Stryer, L. , Biochemistry. 6th ed. 2006. 
17. Harman, D., The biologic clock: the mitochondria? J Am Geriatr Soc, 1972. 20(4): p. 145-7. 
18. Bandy, B. and A.J. Davison, Mitochondrial mutations may increase oxidative stress: 
Implications for carcinogenesis and aging? Free Radical Biology and Medicine, 1990. 8(6): p. 
523-539. 
19. Kandola, K., A. Bowman, and M.A. Birch-Machin, Oxidative stress - A key emerging impact 
factor in health, ageing, lifestyle and aesthetics. International Journal of Cosmetic Science, 
2015. 37: p. 1-8. 
20. Hayakawa, M., et al., Age-associated oxygen damage and mutations in mitochondrial DNA in 
human hearts. Biochemical and Biophysical Research Communications, 1992. 189(2): p. 979-
985. 
21. Hudson, E.K., et al., Age-associated change in mitochondrial DNA damage. Free Radical 
Research, 1998. 29(6): p. 573-579. 
22. Kujoth, C.C., et al., Medicine: Mitochondrial DNA mutations, oxidative stress, and apoptosis 
in mammalian aging. Science, 2005. 309(5733): p. 481-484. 
23. Trifunovic, A., et al., Somatic mtDNA mutations cause aging phenotypes without affecting 
reactive oxygen species production. Proceedings of the National Academy of Sciences of the 
United States of America, 2005. 102(50): p. 17993-17998. 
24. Thayer, R.E., et al., A maternal line study investigating the 4977-bp mitochondrial DNA 
deletion. Experimental Gerontology, 2003. 38(5): p. 567-571. 
25. Birket, M.J. and M.A. Birch-Machin, Ultraviolet radiation exposure accelerates the 
accumulation of the aging-dependent T414G mitochondrial DNA mutation in human skin. 
Aging Cell, 2007. 6(4): p. 557-564. 
26. Trounce, I., E. Byrne, and S. Marzuki, DECLINE IN SKELETAL MUSCLE MITOCHONDRIAL 
RESPIRATORY CHAIN FUNCTION: POSSIBLE FACTOR IN AGEING. The Lancet, 1989. 333(8639): 
p. 637-639. 
27. Velarde, M.C., et al., Mitochondrial oxidative stress caused by Sod2 deficiency promotes 
cellular senescence and aging phenotypes in the skin. Aging, 2012. 4(1): p. 3-12. 
28. Lapointe, J., et al., The submitochondrial distribution of ubiquinone affects respiration in 
long-lived Mclk1+/- mice. Journal of Cell Biology, 2012. 199(2): p. 215-224. 
29. Dillin, A., et al., Rates of behavior and aging specified by mitochondrial function during 
development. Science, 2002. 298(5602): p. 2398-2401. 
30. Barja, G., Updating the Mitochondrial Free Radical Theory of Aging: An Integrated View, Key 
Aspects, and Confounding Concepts. Antioxidants & Redox Signaling, 2013. 19(12): p. 1420-
1445. 
31. Yun, J. and T. Finkel, Mitohormesis. Cell Metabolism, 2014. 19(5): p. 757-766. 
32. Sohal, R.S. and W.C. Orr, The Redox Stress Hypothesis of Aging. Free radical biology & 
medicine, 2012. 52(3): p. 539-555. 
33. Morley, A.A. and K.J. Trainor, Lack of an effect of vitamin E on lifespan of mice. 
Biogerontology, 2001. 2(2): p. 109-112. 
34. Perez, V.I., et al., Is the oxidative stress theory of aging dead? Biochim Biophys Acta, 2009. 
1790(10): p. 1005-14. 
35. Navarro, A., et al., Vitamin E at high doses improves survival, neurological performance, and 
brain mitochondrial function in aging male mice. American Journal of Physiology - Regulatory 
Integrative and Comparative Physiology, 2005. 289(5 58-5): p. R1392-R1399. 
36. Ristow, M. and K. Schmeisser, Mitohormesis: Promoting Health and Lifespan by Increased 
Levels of Reactive Oxygen Species (ROS). Dose-Response, 2014. 12(2): p. 288-341. 
37. Aunan, J.R., et al., Molecular and biological hallmarks of ageing. British Journal of Surgery, 
2016. 103(2): p. e29-e46. 
38. Bowman, A. and M.A. Birch-Machin, Age-Dependent Decrease of 
Mitochondrial&#xa0;Complex II Activity in&#xa0;Human Skin Fibroblasts. Journal of 
Investigative Dermatology. 
39. Passos, J.F., et al., Mitochondrial dysfunction accounts for the stochastic heterogeneity in 
telomere-dependent senescence. PLoS Biology, 2007. 5(5): p. 1138-1151. 
40. Birket, M.J., et al., The relationship between the aging- and photo-dependent T414G 
mitochondrial DNA mutation with cellular senescence and reactive oxygen species 
production in cultured skin fibroblasts. Journal of Investigative Dermatology, 2009. 129(6): p. 
1361-1366. 
41. Passos, J.F., et al., Feedback between p21 and reactive oxygen production is necessary for cell 
senescence. Molecular Systems Biology, 2010. 6. 
42. Boulton, S.J. and M.A. Birch-Machin, Impact of hyperpigmentation on superoxide flux and 
melanoma cell metabolism at mitochondrial complex II. FASEB Journal, 2015. 29(1): p. 346-
353. 
43. Correia‐Melo, C., et al., Mitochondria are required for pro‐ageing features of the senescent 
phenotype. The EMBO Journal, 2016. 
44. Krutmann, J. and P. Schroeder, Role of mitochondria in photoaging of human skin: The 
defective powerhouse model. Journal of Investigative Dermatology Symposium Proceedings, 
2009. 14(1): p. 44-49. 
45. Boulton, S.J., et al., Skin manifestations of mitochondrial dysfunction: More important than 
previously thought. Experimental Dermatology. 24(1): p. 12-13. 
46. Oyewole, A.O., et al., Comparing the effects of mitochondrial targeted and localized 
antioxidants with cellular antioxidants in human skin cells exposed to UVA and hydrogen 
peroxide. The FASEB Journal, 2014. 28(1): p. 485-494. 
47. Birch-Machin, M.A., E.V. Russell, and J.A. Latimer, Mitochondrial DNA damage as a 
biomarker for ultraviolet radiation exposure and oxidative stress. British Journal of 
Dermatology, 2013. 169: p. 9-14. 
48. Kimeswenger, S., et al., Infrared A Radiation Promotes Survival of Human Melanocytes 
Carrying Ultraviolet Radiation-Induced DNA Damage. Experimental Dermatology, 2016: p. 
n/a-n/a. 
49. Roxanna Koohgoli, L.H., Simon Wilkinson, Bhaven Chavan and Mark A Birch-Machin, Bad air 
gets under your skin. Experimental Dermatology, 2016. 
50. Meyer, J.N., et al., Mitochondria as a Target of Environmental Toxicants. Toxicological 
Sciences, 2013. 
51. Hou, L., et al., Airborne particulate matter and mitochondrial damage: a cross-sectional 
study. Environmental Health, 2010. 9(1): p. 1-9. 
52. Quan, C., et al., Age-associated reduction of cell spreading induces mitochondrial DNA 
common deletion by oxidative stress in human skin dermal fibroblasts: implication for human 
skin connective tissue aging. Journal of Biomedical Science, 2015. 22(1): p. 62. 
53. Staberg, B., et al., The carcinogenic effect of UVA irradiation. Journal of Investigative 
Dermatology, 1983. 81(6): p. 517-519. 
54. Brugè, F., et al., Prevention of UVA-Induced Oxidative Damage in Human Dermal Fibroblasts 
by New UV Filters, Assessed Using a Novel <italic>In Vitro</italic> Experimental System. PLoS 
ONE, 2014. 9(1): p. e83401. 
55. Haywood, R., et al., Sunscreens Inadequately Protect Against Ultraviolet-A-Induced Free 
Radicals in Skin: Implications for Skin Aging and Melanoma? Journal of Investigative 
Dermatology, 2003. 121(4): p. 862-868. 
56. Pinnell, S.R., et al., Topical L-ascorbic acid: Percutaneous absorption studies. Dermatologic 
Surgery, 2001. 27(2): p. 137-142. 
57. Matsui, M.S., et al., Non-sunscreen photoprotection: Antioxidants add value to a sunscreen. 
Journal of Investigative Dermatology Symposium Proceedings, 2009. 14(1): p. 56-59. 
58. Yin, F., et al., Mitochondrial function in ageing: coordination with signalling and 
transcriptional pathways. The Journal of Physiology, 2015: p. n/a-n/a. 
59. Chakrabarti, S., et al., Mitochondrial Dysfunction during Brain Aging: Role of Oxidative Stress 
and Modulation by Antioxidant Supplementation. Aging and Disease, 2011. 2(3): p. 242-256. 
 
 
  
  
Figure 1. How solar light may interact with the vicious cycle theory of ageing. 
Solar light is able to interact with and cause damage to mitochondria, either by causing direct 
mtDNA damage, or via an increase in ROS production. MtDNA damage may then cause an 
increase in mitochondrial dysfunction, and possibly a further increase of ROS. ROS 
generated may have a positive or negative effect on age-related processes and lifespan, 
depending on the levels, a term known as Mitohormesis. 
 
 
